← Back to headlines
Omada Health outlines 22% revenue growth target for 2026 while launching new GLP-1 and cholesterol programs
Omada Health has outlined a target of 22% revenue growth by 2026 and is launching new GLP-1 and cholesterol management programs.
6 Mar, 06:17 — 6 Mar, 06:17
Sources
Showing 1 of 1 sources
